Rhenman & Partners Asset Management AB - Q4 2022 holdings

$958 Million is the total value of Rhenman & Partners Asset Management AB's 93 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 12.2% .

 Value Shares↓ Weighting
LLY SellLILLY ELI & CO$32,193,920
-8.3%
88,000
-9.3%
3.36%
-8.7%
ABC BuyAMERISOURCEBERGEN CORP$28,667,830
+34.1%
173,000
+27.2%
2.99%
+33.6%
MDT BuyMEDTRONIC PLC$27,202,000
+29.8%
350,000
+45.8%
2.84%
+29.3%
BSX SellBOSTON SCIENTIFIC CORP$27,067,950
-9.7%
585,000
-15.8%
2.82%
-10.0%
REGN BuyREGENERON PHARMACEUTICALS$26,695,130
+11.4%
37,000
+15.6%
2.78%
+11.0%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$26,286,460
+28.0%
254,000
+7.2%
2.74%
+27.6%
MRK  MERCK & CO. INC$23,854,250
+9.6%
215,0000.0%2.49%
+9.3%
GILD  GILEAD SCIENCES INC$23,179,500
+9.4%
270,0000.0%2.42%
+9.0%
VRTX SellVERTEX PHARMACEUTICALS INC$23,102,400
-22.9%
80,000
-16.7%
2.41%
-23.2%
ANTM BuyELEVANCE HEALTH INC$23,083,650
+5.5%
45,000
+12.5%
2.41%
+5.2%
THC BuyTENET HEALTHCARE CORP$22,967,893
+50.5%
470,750
+36.8%
2.40%
+49.9%
TMO SellTHERMO FISHER SCIENTIFIC INC$22,027,600
-18.4%
40,000
-23.8%
2.30%
-18.7%
HCA BuyHCA HEALTHCARE INC$21,596,400
+131.0%
90,000
+109.3%
2.25%
+130.1%
BDX SellBECTON DICKINSON & CO$21,106,900
+5.2%
83,000
-2.4%
2.20%
+4.9%
ABBV SellABBVIE INC$21,009,300
-4.1%
130,000
-13.1%
2.19%
-4.4%
CI SellCIGNA CORP NEW$20,543,080
-15.2%
62,000
-17.3%
2.14%
-15.5%
JAZZ SellJAZZ PHARMACEUTICALS PLC$20,391,680
+7.8%
128,000
-2.7%
2.13%
+7.5%
UNH SellUNITED HEALTH GROUP INC$20,146,840
-33.8%
38,000
-30.7%
2.10%
-34.0%
HUM SellHUMANA INC$19,975,410
-18.7%
39,000
-11.4%
2.08%
-18.9%
PFE  PFIZER INC$17,934,000
+10.1%
350,0000.0%1.87%
+9.7%
JNJ  JOHNSON & JOHNSON$17,665,000
+1.5%
100,0000.0%1.84%
+1.2%
ALNY SellALNYLAM PHARMACEUTICALS INC$17,348,450
+11.6%
73,000
-2.7%
1.81%
+11.2%
BNTX BuyBIONTECH SEsponsored ads$16,373,980
+20.2%
109,000
+10.1%
1.71%
+19.7%
CVS SellCVS HEALTH CORP$15,935,490
-25.2%
171,000
-24.0%
1.66%
-25.5%
COO BuyCOOPER COS INC$15,541,490
+21.2%
47,000
+0.2%
1.62%
+20.7%
INSP SellINSPIRE MED SYS INC$15,364,680
+25.1%
61,000
-3.2%
1.60%
+24.7%
MCK SellMCKESSON CORP$14,629,680
-24.9%
39,000
-22.0%
1.53%
-25.2%
AXNX BuyAXONICS INC$14,381,900
-6.4%
230,000
+9.5%
1.50%
-6.7%
MRTX BuyMIRATI THERAPEUTICS INC$13,593,000
+2.5%
300,000
+52.2%
1.42%
+2.1%
DHR SellDANAHER CORPORATION$13,271,000
-15.0%
50,000
-19.4%
1.38%
-15.2%
HRMY BuyHARMONY BIOSCIENCES HLDGS IN$13,224,000
+7.3%
240,000
+1.3%
1.38%
+7.0%
ABT  ABBOTT LABS$12,845,430
+11.0%
117,0000.0%1.34%
+10.6%
EW BuyEDWARDS LIFESCIENCES CORP$10,743,840
+18.7%
144,000
+15.2%
1.12%
+18.2%
SILK BuySILK RD MED INC$10,351,782
+51.5%
195,871
+26.4%
1.08%
+51.0%
APLS SellAPELLIS PHARMACEUTICALS INC$10,342,000
-22.3%
200,000
-9.1%
1.08%
-22.5%
NBIX BuyNEUROCRINE BIOSCIENCES INC$10,152,400
+6.3%
85,000
+2.4%
1.06%
+5.8%
CYTK BuyCYTOKINETICS INC$9,911,874
+8.1%
216,322
+3.0%
1.03%
+7.7%
SWAV BuySHOCKWAVE MEDICAL INC$9,663,670
+64.8%
47,000
+135.0%
1.01%
+64.2%
OM BuyOUTSET MED INC$9,295,200
+75.9%
360,000
+5.9%
0.97%
+75.4%
ISEE BuyIVERIC BIO INC$9,206,300
+5.4%
430,000
+17.8%
0.96%
+5.1%
IMCR  IMMUNOCORE HLDGS PLCads$8,560,500
-0.1%
150,0000.0%0.89%
-0.4%
PODD  INSULET CORP$8,537,310
+13.8%
29,0000.0%0.89%
+13.4%
RPRX  ROYALTY PHARMA PLC$8,496,800
-6.6%
215,0000.0%0.89%
-7.0%
PRVA BuyPRIVIA HEALTH GROUP INC$8,402,700
-9.4%
370,000
+33.6%
0.88%
-9.7%
DVAX BuyDYNAVAX TECHNOLOGIES CORP$8,336,642
-0.7%
783,519
+6.8%
0.87%
-1.0%
BIIB SellBIOGEN INC$8,307,600
-10.6%
30,000
-8.5%
0.87%
-10.9%
RVNC BuyREVANCE THERAPEUTICS INC$8,085,480
-6.6%
438,000
+12.9%
0.84%
-6.8%
XNCR  XENCOR INC$7,657,739
-7.0%
294,0760.0%0.80%
-7.3%
TECH NewBIO-TECHNE CORP$7,459,20090,000
+100.0%
0.78%
IMGN BuyIMMUNOGEN INC$7,440,000
+13.9%
1,500,000
+36.4%
0.78%
+13.5%
NTRA BuyNATERA INC$6,628,050
+76.4%
165,000
+106.2%
0.69%
+76.1%
ITCI  INTRA-CELLULAR THERAPIES INC$6,615,000
+15.9%
125,0000.0%0.69%
+15.4%
KRTX BuyKARUNA THERAPEUTICS INC$5,895,000
+34.4%
30,000
+50.0%
0.62%
+34.0%
WST BuyWEST PHARMACEUTICAL SVSC INC$5,883,750
+50.4%
25,000
+47.1%
0.61%
+49.8%
ESPR  ESPERION THERAPEUTICS INC NE$5,607,000
-23.4%
900,0000.0%0.58%
-23.6%
VEEV  VEEVA SYS INC$5,567,610
-3.9%
34,5000.0%0.58%
-4.3%
IOVA BuyIOVANCE BIOTHERAPEUTICS INC$5,523,375
+16.0%
864,378
+69.5%
0.58%
+15.4%
NVST BuyENVISTA HOLDINGS CORPORATION$5,515,146
+16.2%
163,800
+13.9%
0.58%
+15.7%
EXAS BuyEXACT SCIENCES CORP$5,446,100
+106.1%
110,000
+44.7%
0.57%
+105.1%
OSH NewOAK STR HEALTH INC$5,377,500250,000
+100.0%
0.56%
SGEN  SEAGEN INC$5,268,910
+1.1%
41,0000.0%0.55%
+0.7%
OLK  OLINK HLDG ABsponsored ads$4,933,618
+38.5%
194,3900.0%0.52%
+38.1%
PHR BuyPHREESIA INC$4,854,000
+42.1%
150,000
+20.0%
0.51%
+41.3%
VRAY  VIEWRAY INC$4,480,000
+4.4%
1,000,0000.0%0.47%
+4.0%
 R1 RCM INC$4,139,100
-38.0%
378,0000.0%0.43%
-38.2%
AGL  AGILON HEALTH INC$4,115,700
-18.7%
255,0000.0%0.43%
-19.1%
IQV NewIQVIA HLDGS INC$4,097,80020,000
+100.0%
0.43%
ALKS  ALKERMES PLC$3,919,500
+15.1%
150,0000.0%0.41%
+14.6%
ALHC BuyALIGNMENT HEALTHCARE INC$3,822,000
+5.0%
325,000
+18.2%
0.40%
+4.7%
GKOS  GLAUKOS CORP$3,712,800
-22.1%
85,0000.0%0.39%
-22.4%
MGTX  MEIRAGTX HLDGS PLC$3,618,796
-10.3%
555,0300.0%0.38%
-10.6%
TDOC  TELADOC HEALTH INC$3,074,500
-20.2%
130,0000.0%0.32%
-20.3%
RLAY NewRELAY THERAPEUTICS INC$2,988,000200,000
+100.0%
0.31%
ARVN BuyARVINAS INC$2,907,850
+17.0%
85,000
+70.0%
0.30%
+16.5%
TXG  10X GENOMICS INC$2,733,000
+34.0%
75,0000.0%0.28%
+33.2%
PHAT  PHATHOM PHARMACEUTICALS INC$2,639,056
+5.9%
235,2100.0%0.28%
+5.4%
SGMO  SANGAMO THERAPEUTICS INC$2,574,800
-28.5%
820,0000.0%0.27%
-28.6%
NVCR  NOVOCURE LTD$2,567,250
+3.8%
35,0000.0%0.27%
+3.5%
NewNUVALENT INC$2,382,40080,000
+100.0%
0.25%
MRSN NewMERSANA THERAPEUTICS INC$2,344,000400,000
+100.0%
0.24%
ALLO  ALLOGENE THERAPEUTICS INC$2,138,600
-38.9%
340,0000.0%0.22%
-39.2%
GTHX  G1 THERAPEUTICS INC$2,009,100
-49.1%
370,0000.0%0.21%
-49.2%
HCAT  HEALTH CATALYST INC$1,913,400
+20.5%
180,0000.0%0.20%
+20.5%
IONS  IONIS PHARMACEUTICALS INC$1,888,500
-14.5%
50,0000.0%0.20%
-14.7%
RIGL  RIGEL PHARMACEUTICALS INC$1,837,622
+105.8%
1,225,0810.0%0.19%
+104.3%
NTLA  INTELLIA THERAPEUTICS INC$1,744,500
-33.9%
50,0000.0%0.18%
-34.1%
STXS  STEREOTAXIS INC$1,650,473
+10.7%
797,3300.0%0.17%
+10.3%
ISRG SellINTUITIVE SURGICAL INC$1,326,750
-89.2%
5,000
-90.0%
0.14%
-89.3%
NKTR  NEKTAR THERAPEUTICS$1,243,000
-39.9%
550,0000.0%0.13%
-40.1%
NKTX  NKARTA INC$1,198,000
-52.5%
200,0000.0%0.12%
-52.7%
EPIX  ESSA PHARMA INC$945,000
-30.0%
375,0000.0%0.10%
-29.8%
IGMS NewIGM BIOSCIENCES INC$850,50050,000
+100.0%
0.09%
 RAPID MICRO BIOSYSTEMS INC$339,000
-61.3%
300,0000.0%0.04%
-62.0%
GH ExitGUARDANT HEALTH INC$0-65,000
-100.0%
-0.34%
PGNY ExitPROGYNY INC$0-90,000
-100.0%
-0.42%
HZNP ExitHORIZON THERAPEUTICS PUB L$0-130,000
-100.0%
-0.85%
ABMD ExitABIOMED INC$0-85,900
-100.0%
-2.27%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UNITEDHEALTH GROUP INC40Q3 20234.0%
BIOMARIN PHARMACEUTICAL INC40Q3 20235.0%
ALKERMES PLC40Q3 20233.3%
LILLY ELI & CO39Q3 20235.8%
CVS HEALTH CORP39Q3 20233.5%
INTRA-CELLULAR THERAPIES INC39Q3 20232.4%
EDWARDS LIFESCIENCES CORP39Q3 20231.7%
VERTEX PHARMACEUTICALS INC38Q3 20234.3%
REVANCE THERAPEUTICS INC38Q3 20230.9%
ABBVIE INC37Q3 20234.4%

View Rhenman & Partners Asset Management AB's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR/A2023-11-13
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11

View Rhenman & Partners Asset Management AB's complete filings history.

Compare quarters

Export Rhenman & Partners Asset Management AB's holdings